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Abstract
Background: Genetic variants in immune regulator genes have been associated with numerous
diseases, including allergies and cancer. Increasing evidence suggests a substantially elevated disease
risk in individuals who carry a combination of disease-relevant single nucleotide polymorphisms
(SNPs). For the genotyping of immune regulator genes, such as cytokines, chemokines and
transcription factors, an oligonucleotide microarray for the analysis of 99 relevant SNPs was
established. Since the microarray design was based on a platform that permits flexible in situ
oligonucleotide synthesis, a set of optimally performing probes could be defined by a selection
approach that combined computational and experimental aspects.
Results: While the in silico process eliminated 9% of the initial probe set, which had been picked
purely on the basis of potential association with disease, the subsequent experimental validation
excluded more than twice as many. The performance of the optimized microarray was
demonstrated in a pilot study. The genotypes of 19 hay-fever patients (aged 40–44) with high IgE
levels against inhalant antigens were compared to the results obtained with 19 age- and sex-
matched controls. For several variants, allele-frequency differences of more than 10% were
identified.
Conclusion: Based on the ability to improve empirically a chip design, the application of candidate-
SNP typing represents a viable approach in the context of molecular epidemiological studies.
Background
Array-based technologies are revolutionizing genomics,
especially the analysis of DNA variation. Array technolo-
gies are not without limitations, however, and one major
drawback is the poor flexibility of typical array formats. It
is cumbersome to create one's own tailored arrays by spot-
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ting DNA. Commercially available microarrays, on the
other hand, either contain a fixed and usually broadly
applicable content or are expensive to purchase with cus-
tomized features. The fixed-content arrays are useful for
taking advantage of the high resolution genetic map of the
human genome that is based on single nucleotide poly-
morphisms [1,1], which define DNA blocks (haplotypes)
[1]. Since SNPs are the most common type of genetic var-
iation between individuals, it makes sense to utilize them
for the localization of disease genes by identifying haplo-
types that are associated with phenotypic traits, especially
in the case of multifactorial diseases [1-5]. As a conse-
quence of such a study, however, further analysis is
required for improving the resolution of the mapping
process or trying to identify the polymorphisms that are
actually responsible for the phenotypic variation. Alterna-
tively to the process described above, one can immedi-
ately focus on the analysis of particular polymorphisms in
candidate genes, if circumstantial evidence indicates their
possible relevance to the occurrence of a disease. In either
approach the production of a customized microarray is
required. Also, experience has demonstrated the need for
a careful design of the experimental set-up in order to
avoid unacceptable error [6].
Irrespective of the algorithm used for the sequence selec-
tion of the probe set, the final functional test of the suita-
bility of an oligonucleotide array for genotyping results
from an empirical analysis of the hybridization perform-
ance of the oligonucleotide probes. In consequence, it is
likely that the initial chip design will be changed by
replacing ill-performing oligonucleotides with alternative
sequences. For this process, the ability to easily change the
chip layout is essential. Light-induced in situ synthesis
controlled by a micro-mirror device [7,8] combines high
synthesis yields of more than 99.5% per condensation [9]
– and therefore good oligonucleotide quality – with the
power of producing oligomer arrays of high density,
reproducible characteristics and flexible layout.
In this study, we present the process of establishing an oli-
gonucleotide microarray based on an on-site in situ syn-
thesis technology for typing DNA samples in immune
regulator genes including cytokines, chemokines and
transcription factors. Genetic variants in immune regula-
tor genes have been associated with numerous diseases,
including allergies and cancer, with apparently an ele-
vated disease risks in individuals that carry a combination
of disease-relevant SNPs. For the array design, we
exploited the flexibility of the GeniomOne device [8]. It
employs a digital projector to synthesize oligonucleotide
array features within channels of a three-dimensional
micro-fluidic reaction carrier. The system allows the syn-
thesis of a probe set of up to 64,000 oligonucleotides on
a single chip, which subsequently can be hybridized with
up to eight samples. For this analysis a microarray that
assays 99 relevant SNPs was established by an iterative
cycle of probe design and experimental evaluation. Subse-
quently, the performance of this microarray was investi-
gated in a pilot study. Hay-fever patients aged 40–44 that
exhibited high IgE levels against inhalant antigens and an
age and sex-matched control group were analyzed.
Results
From a case-control study on hay-fever [10], 19 cases with
the most extreme plasma IgE levels against inhalant anti-
gens and 19 age- and sex-matched non-atopic controls
were selected for the project. Originally, 141 SNPs in
cytokine genes and other immune regulatory factors were
selected from published studies and SNP-databases [11-
13]. If possible, SNPs with known or potential functional
relevance and allele frequency information were selected.
Also, sequence complexity between the probes was meant
to be similar, since it is well established that the rate of
reassociation depends on sequence complexity [14]. In
addition, the initial compilation was based on theoretical
calculations of interactions between all oligonucleotide
probes and PCR fragments. The program "SNP Cross-
Checker" by Febit GmbH was used to check the cross reac-
tivity between oligoprobes and template sequences
reducing the number of PCR-products by 13 to 128. The
threshold of maximally possible homology between 23
mere oligoprobe and template sequences was set to 85%.
It takes into account that if within the 23 nucleotides of a
probe, 20 nucleotides will basepairing with a template,
this will produce sufficiently stable complex to produce
false positive signals in the genotyping analysis.
Theoretically the probe properties could be assessed basis
their sequence similarity and hybridization properties.
Experimentally "bad" probe has low specificity, sensitivity
and uniformity under given reaction conditions (temper-
ature, base composition, salt concentration, hybridization
time). Specificity and stability of DNA duplex formation
strongly depend on sequence and base composition
[15,16]. Also, the target sequence on either side of the SNP
position plays an important role since secondary struc-
tures may strongly affect the hybridization behavior of a
sample [17]. Therefore, it is frequently insufficient to pre-
dict hybridization performance merely on the basis of the-
oretical calculations. Consequently, we analyzed and
optimized the experimental parameters of SNP position
in the oligonucleotide and the overall length of the probes
as well as hybridization temperature and duration. For
each SNP, all four possible sequence variations were
applied to the chip. One of the probes is designed to be
perfectly complementary to a short stretch of the reference
sequence (perfect match – PM) and the other three are
identical to the first, except at the interrogation position,
where one of the other three bases is substituted (mis-BMC Genomics 2007, 8:282 http://www.biomedcentral.com/1471-2164/8/282
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matches – MM). PM/MM scheme enables in addition sub-
tract directly both the background level and cross-
hybridization signals providing thus with redundancy
required for the reliable microarray analysis. The perfect
match probe (PM) is designed complementary to the tar-
get sequence and the so-called mismatch probe (MM) is
identical with the PM, except the base in the middle of the
sequence. Ideally, there is 30-fold difference in the signal
intensities of PM vs. MM oligo. In hybridization the oligo
signal intensity depends directly of its sequence GC con-
tent. Depending on sequence content (high G/C content)
the MM oligo can result sufficiently high signal and inter-
fere discrimination between PM and MM signals. In such
cases the entire set of 24 oligoprimers, specially designed
for detection of one SNP from sense and antisense
strands, is underperforming and has to be left out of array
design. In addition, we tested positional effects by moving
the polymorphic nucleotide from the center to positions
+2 and -2 as well as +1 and -1 of the oligonucleotide
probes (Fig. 1). This shift resulted in differences in signal
intensities but did not add to the overall amount of infor-
mation that could be gathered from an experiment. In
consequence, we decided to use only probes that con-
tained the respective SNP in a central position but placed
three copies of the same oligosequence at different loca-
tions of the microarray.
Design a 23 mer oligonucleotide for SNP detection Figure 1
Design a 23 mer oligonucleotide for SNP detection. In (a) the relevant PCR-product of 166 bp is shown. (b) exhibits the 
set of oligonucleotides (12 for sense and 12 for antisense strand; at n = 0 the allele is located in the middle of the oligomer, at 
n = -2 and n = +2 the SNP is shifted by 2 nucleotides to the left and right, respectively.BMC Genomics 2007, 8:282 http://www.biomedcentral.com/1471-2164/8/282
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Table 1: Relative allele frequences of SNPs genotyped in 19 hay fever patients with extreme IgE phenotype and 19 non-atopic 
controls.
SNP Nr. SNP name SNP identifier Allele 1 Relative frequence 
of allele 1 in case 
sample
Relative frequence 
of allele 1 in 
control sample
1 IL-2_1 rs2069772 T 0.58 0.83
2 IL-2_2 rs2069763 G 0.67 0.61
3 IL-10_4 rs1800894 G 1.00 1.00
4 IL-10_5 rs1800871 C 0.77 0.83
5 IL-10_6 rs1800872 C 0.77 0.83
6 TNFA_7 rs11565 C 0.85 0.92
7 TNFA_8 rs673 A 0.03 0.03
8 TNFA_9 rs1800629 A 0.16 0.05
9 TNFA_10 rs361525 A 0.11 0.03
10 IL4_11 rs2243246 T 0.95 0.86
11 IL4_12 rs2243250 C 1.00 1.00
12 IL4_13 rs34185442 C 1.00 1.00
13 IL4_14 rs2970874 C 1.00 0.97
14 IL6_16 rs1800797 G 0.63 0.60
15 IL6_16 rs1800796 G 1.00 1.00
16 IL6_17 rs1800795 G 0.63 0.47
17 IL4R_18 rs1801275 A 0.87 0.68
18 IL4R_19 rs1805011 C 0.05 0.13
19 IL4R_20 rs8832 G 0.75 0.62
20 IL4R_21 rs1805015 T 1.00 0.89
21 IL4R_22 rs1805010 A 0.70 0.56
22 IL12p40_23 rs3124 C 1.00 1.00
23 STAT6_24 rs167769 A 0.32 0.20
24 STAT6_25 rs324015 G 0.72 0.82
25 STAT6_26 rs703817 G 0.50 0.38
26* STAT6_27 rs4559 A 0.27 0.25
27 IFNG_28 rs2234685 A 1.00 1.00
28 IFNG_29 rs1861493 T 0.69 0.69
29 IFNG_30 rs2234687 C 1.00 1.00
30* IFNG_31 rs2430561 T 0.50 0.38
31 IFNGR2_34 rs1802585 C 1.00 1.00
32 IFNGR2_35 rs1059293 T 0.39 0.50
33 IFNGR2_36 rs9808753 A 0.86 0.94
34 IRF1_37 rs839 G 0.74 0.89
35* IRF1_38 rs9282762 A 0.42 0.60
36* IRF2_40 rs1131553 G 0.32 0.50
37 IL8_41 rs1175 A 0.41 0.47
38 IL8_42 rs2227307 G 0.42 0.50
39 IL13_43 rs20541 G 0.89 0.79
40 IL13_44 rs1800925 C 0.88 0.82
41* IL18_47 rs1946518 G 0.63 0.67
42* IL18_48 rs1946519 C 0.87 0.71
43* IL1B_49 rs16944 T 0.16 0.15
44 IL1B_50 rs1143627 C 0.36 0.38
45 IL1B_51 rs1799916 T 1.00 1.00
46 IL1A_52 rs17561 G 0.64 0.74
47 IL1A_53 rs1800587 T 0.36 0.31
48 IL9_56 rs1799962 A 1.00 1.00
49 TNFR1_60 rs1800692 C 0.63 0.53
50 TNFR1_61 rs1800693 A 0.53 0.72
51* TNFRSF6_62 rs2234768 T 0.00 1.00
52 LTA_65 rs1800683 A 1.00 1.00
53 LTA_66 rs1041981 A 0.29 0.19
54 LTA_67 rs909253 G 0.25 0.19
55 IL1RN_68 rs2234676 G 0.86 0.74
56 IL1RN_69 rs419598 T 0.87 0.88
57 CTLA4_70 rs2384137 G 0.11 0.06BMC Genomics 2007, 8:282 http://www.biomedcentral.com/1471-2164/8/282
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Furthermore, different temperatures for hybridisation
(40°C, 45°C, 50°C, and 55°C) and changes in hybridisa-
tion time from one to four hours were compared. The
time of hybridisation in this experiment had little influ-
ence on number of correct and false signals. However,
increased hybridisation temperature at 50°C or 55°C
reduced cross hybridisation at least 5% and lowered gen-
eral amount of positive signal to 60% and 40% (respec-
tively). Reduced stringency by decreased hybridisation
temperature maximized the overall number and intensity
of signals, but this was accompanied with 30% increase of
unspecific hybridisation signals.
We also varied probe length, synthesizing on the same
chip oligonucleotides of 19, 21, 23, 25 and 27 nucle-
otides. While longer sequences usually produce higher
signal intensities, shorter oligonucleotides permit better
discrimination of single base differences due to the more
pronounced destabilizing effect of a mismatch. As
expected, the signal intensities of both the fully matched
(I1) and the mismatch probes (I2) increased with length
while discrimination (I1/I2) improved the shorter the oli-
gonucleotides were (Fig. 2). Measured signal intensity (I1)
increases clearly with higher nucleotides number in the
sequence of oligonucleotide-probe: I1 (27 bp) > I1 (19 bp)
(Fig. 3). Same effect is obtained for MM (I2) oligo-probes
as well. Though the discrimination between PM/MM
58 NFKBIA_72 rs1800439 G 0.53 0.56
59 IL8RB_77 rs2230054 T 0.06 0.17
60 ICAM1_78 rs1799969 A 1.00 0.97
61* ICAM1_79 rs5498 G 0.61 0.64
62 IL3_81 rs40401 G 0.95 0.94
63 IL3_82 rs31480 G 0.84 0.82
64 MCP1_87 rs4611511 A 0.89 0.92
65 MCP1_88 rs34020694 A 0.87 0.87
66 RANTES_89 rs2107538 G 0.88 0.91
67 RANTES_90 rs2280788 C 0.95 0.95
68 CCR5_91 rs1799863 A 0.03 0.00
69 CCR2_94 rs1799865 T 0.50 0.56
70 C5_95 rs17611 G 0.66 0.50
71 C5_96 rs17612 C 0.11 0.06
72 P2X7_97 rs3751143 C 0.06 0.03
73 IL7R_106 rs1494555 G 0.34 0.35
74 PRF1_107 rs885822 T 0.83 0.94
75 TLR2_108 rs1804965 G 1.00 1.00
76 TCL1B_109 rs1064017 G 0.44 0.56
77 CCR5_110 rs1800452 G 1.00 1.00
78 IL11_111 rs1126757 A 0.38 0.44
79 IL11_112 rs2298885 G 0.61 0.85
80 IL8RA_117 rs2234671 G 0.40 0.44
81* IL1L1_118 rs1800930 A 0.78 0.83
82* CD36_119 rs1334512 G 0.96 0.85
83 VDR_121 rs1544410 G 0.31 0.44
84* VDR_122 rs7975232 T 0.73 0.54
85 IL5RA_123 rs2290610 A 0.83 0.61
86 IL5R_124 rs2069812 C 0.79 0.78
87 IL5R_125 rs2069818 C 1.00 1.00
88 CX3CR1_126 rs3732379 G 0.68 0.67
89 CX3CR1_127 rs3732378 C 0.78 0.74
90* TNFRSF1B_128 rs1061622 T 0.88 0.65
91 TNFRSF1B_129 rs1061624 A 0.31 0.47
92 TNFRSF1B_130 rs3397 T 0.88 0.79
93* TNFRSF1A_131 rs887477 G 0.54 0.35
94 TNFRSF1A_132 rs4149570 G 0.76 0.53
95 IL4R_135 rs1805016 T 1.00 1.00
96 IL6_137 rs20069860 A 0.97 1.00
97* IL9_138 rs20069885 C 1.00 0.96
98* NKFB_139 rs1020759 C 1.00 1.00
99 GATA3_141 rs57013 A 0.72 0.58
* The SNP detection reproducibility <80%
Table 1: Relative allele frequences of SNPs genotyped in 19 hay fever patients with extreme IgE phenotype and 19 non-atopic controls. 
(Continued)BMC Genomics 2007, 8:282 http://www.biomedcentral.com/1471-2164/8/282
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according to the calculated relation of measured intensi-
ties (I1/I2) is higher for shortest set of oligo-probes as 19
bp (5,3...3,6) and the lowest with 27 bp (1,7...1,6) ones.
Variation of I1/I2 among probes within the same number
of nucleotides comes mainly from GC content differ-
ences/variations of probe-sequence itself. Why longer MM
sequences give higher signal comparing to shorter ones
comes mainly from weaker destabilizing effect of non-
complimentary nucleotide on formation of double-
stranded complex between probe and target DNA.
Tests at different hybridization temperatures (40–55°C)
produced the overall best results for the majority of SNPs
with 23-mer probes and 3 to 4 hours of hybridization at
45°C. Finally, the selected set of oligoprobes, as well as
the hybridization conditions, were tested in addition with
4 genomic DNA samples of control individuals. These
control experiments had 5-fold redundancy. Concord-
ance of analyzed genotypes were compared individually.
For selecting the best performing oligoprobes in the initial
optimization experiments one test-DNA with good qual-
ity was used. All hybridization reactions from chip design
step were repeated 3 times. During the optimization proc-
ess, we identified several oligonucleotide probes that did
not perform irrespective of the chosen hybridization con-
ditions (e.g., Fig. 2). Apparently, the previously described
selection basis of cross-reactivity could be even more
The dependence of signal intensity on oligonucleotide length Figure 2
The dependence of signal intensity on oligonucle-
otide length. Hybridization was done at 45°C. I1/I2 labels 
the ratio of the signal at the full-match oligonucleotide and 
the signals at the mismatched oligonucleotides. 27, 25, 23, 21 
and 19 indicates the length of oligomers. The SNP was 
located either at the center of the oligonucleotides (0) or 
shifted by two bases in either direction (+1, -1).
Differences in the performance of oligonucleotides Figure 3
Differences in the performance of oligonucleotides. Set 1 to 6 label the oligonucleotides designed for detecting a SNP. 
Each column indicates the signal intensity at the oligomers that represent (left to right) the A, G, C or T variant of a sequence. 
Sets 1 to 3 are the data produced on replicate microarray positions that represent one strand, while sets 4 to 6 indicate the 
signal intensities produced by the complementary DNA strand. Panel (1) shows the result obtained for a heterozygous sample, 
panel (2) a homozygous sample. Panel (3) exhibits data obtained with an oligonucleotide that was predicted in silico to perform 
well but failed in the experiment. In panel (4) a result of an oligomer with a high degree of cross-hybridization is presented.BMC Genomics 2007, 8:282 http://www.biomedcentral.com/1471-2164/8/282
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stringent e.g. we should allow less base pairing. Following
experimental tests revealed additional oligoprobe sets
falling out from final chip design because of the same rea-
son. Herewith, basis on experimental results, the thresh-
old for software based oligo probe selection could be set
on 80% allowing less base pairing (and less false signals
due to nonspecific oligo hybridization) than 85%. In
total, 29 out of the 128 SNPs (22%) could not be analyzed
adequately. The respective oligomer probes that had been
defined as good by the in silico selection process were
empirically found to be ill-performing in real hybridiza-
tions. Either the absolute signal intensity was too low to
permit a statistically solid analysis or the discriminative
effect was insufficient. The ratio between PM and MM
oligo signal intensities is supposed to be at least 1/3 (Fig.
3). The high number of failing oligonucleotides illustrates
the need for a careful experimental validation of in silico
designed microarrays.
Using the optimized microarray, we performed genotyp-
ing analyses at 99 SNPs in 68 genes that have a putative
functional significance for the occurrence of hay-fever.
From a case-control study on hay-fever [10], 19 cases with
the most extreme plasma IgE levels against inhalant anti-
gens and 19 age- and sex-matched non-atopic controls
were selected. Informed consent of the participants was
given in writing and the local ethics committee approved
the study. PCR-amplifications of the relevant DNA-
regions were performed either individually or in pools of
5 or 10 samples. While all pentaplex reactions yielded a
product for each individual band, two decaplex amplifica-
tions failed to produce 1 out of the expected 10 amplicons
(Fig. 4). The 99 products were pooled prior to labelling
and hybridized concomitantly (Fig. 5). For each sample,
analysis was repeated up to four times. The observed allele
frequencies are presented in Table 1. To assess the accu-
racy of the genotyping, ten PCR-products of heterozygote
calls obtained from the microarray analyses were sub-
jected to gel-based DNA sequencing for confirmation. In
all cases, the results were in full agreement.
Hybridization experiments for all studied 38 individuals
were repeated twice.
16% of SNPs presented only one allele in the 38 studied
samples. For 14 samples (7 cases and 7 controls) the call
rate for all variants was above 90%. And in one case it was
below 80% due to the low quality of this particular DNA
sample. For 17 SNPs the amplification step basically
failed due to low quality of clinical genomic DNA sam-
ples. After exclusion of these particular 17 SNPs (indicated
with an asterisk in Tab. 1) that performed poorly in
hybridizations the average concordance was 93%. From
the variants with high quality data, five SNPs in the genes
IL2 (rs2069772), TCL1B (rs1064017), IL11 (rs2298885),
IL5RA (rs2290610) and TNFRSF1A (rs4149570) had p-
values smaller than 0.05 for the association of carrying the
mutant allele with the high IgE phenotype. The
homozygous genotype A for the IL5 receptor alpha (IL5RA
Ile129 Val) was associated with a 6.8-fold risk (95% con-
fidence interval, 1.6–29.1) of a high IgE phenotype.
Discussion
An oligonucleotide microarray was produced using Gen-
iomOne device to facilitate the screening of single nucle-
otide polymorphisms in several genes that are associated
with hay-fever as a pilot project. Based on an in silico
design, the selected set of oligonucleotides was optimized
by a subsequent experimental analysis. While the in silico
process eliminated 9% of the initially 141 SNPs that had
been picked purely on the basis of a potential association
with the occurrence of hay-fever, the subsequent experi-
mental validation eliminated another 20% of these oli-
gomers, more than twice as many. This result illustrates
the importance of experimental validation of the microar-
ray designs. Even in analyses that are based on a continu-
ous detection of the hybridization and dissociation
process (dynamic allele-specific hybridization) [18] the
selection is critical, although an analysis of the association
and dissociation curves of the duplexes permit a more dis-
criminative and accurate SNP detection.
The reasons for the failing probes could be manifold [19].
Although only short fragments were hybridized, second-
ary structures formed either within one sample molecule
or between different targets could cause inefficient bind-
ing to the array-bound probe molecules. Also, it is well
known that dangling ends of the target molecules may
have a profound effect on the hybridization [20]. Docu-
mentation of the effectiveness of the genotyping ability of
Image of a simultaneous hybridization of 99 PCR-products to  an in situ synthesized oligonucleotide microarray Figure 5
Image of a simultaneous hybridization of 99 PCR-
products to an in situ synthesized oligonucleotide 
microarray. Usually, the features were scrambled across 
the array. For illustrative purposes, they were placed next to 
each other in this particular experiment.BMC Genomics 2007, 8:282 http://www.biomedcentral.com/1471-2164/8/282
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particular sets of oligonucleotide probes is essential for a
study of high accuracy. Use of flexible in situ synthesized
oligonucleotide microarrays to such ends appears to be an
efficient and attractive method for fast and cost-efficient
pre-screening of candidate SNPs for an eventual high-
throughput genotyping.
GeniomOne allows synthesizing 8 × 8.000 probes per
array overnight and test them right after in hybridization
experiments. In this way many combinations can be
tested in parallel without additional cost, which allows
selecting an optimal set of oligoprobes for the following
experiments. This is a big advantage of GeniomOne tech-
nology.
In the analysis of the 38 DNA samples of hay-fever cases
and controls, we were able to identify at least five poly-
morphisms in immune regulator genes that contribute to
the extreme IgE phenotype and deserve further testing. For
22% of the selected SNPs, only one genotype was seen in
38 individuals. For several variants, allele-frequency dif-
ferences between cases and controls exceeded 10%. These
include non-synonymous variants in the IL5 receptor
alpha (IL5RA  Ile129 Val) and TCL1B  (Gly93Arg), pro-
moter polymorphisms in IL2 (-330 T/G) and TNFRSF1A
(-609 G/T), and a polymorphism in the 3' UTR of IL11.
IL5RA is a crucial factor in IL5 signalling and a contributor
to the genetics of atopy in mice [21]. The extreme pheno-
type design of the study performed here may be an effi-
cient alternative for the identification of disease-relevant
sequence variants.
Conclusion
Based on a platform that permits flexible in situ oligonu-
cleotide synthesis, a set of optimally performing probes
could be defined by a selection approach that combined
computational and experimental aspects. The final design
achieved by this process permitted an effective discrimina-
tion of both homo- and heterozygote polymorphisms in
hay-fever patients. Allele-frequencies of more than 10%
could be identified.
Methods
Microarray synthesis
All analysis steps, (i) in situ synthesis of the oligonucle-
otide microarray, (ii) hybridization of the labeled PCR-
product mixture and (iii) detection of the signal intensi-
ties were performed with the GeniomOne device of febit
Gel-electrophoretic separation of the products of multiplex-PCR Figure 4
Gel-electrophoretic separation of the products of multiplex-PCR. Two decaplex amplifications are shown in compar-
ison to the respective individual reactions. In both cases presented here, one product was not amplified in the multiplex reac-
tion while the reaction worked fine in the individual amplification.BMC Genomics 2007, 8:282 http://www.biomedcentral.com/1471-2164/8/282
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Table 2: Primer sequences used for PCR-amplification of the SNP-regions.
No. SNP Name SNP ID Forward Primer (5'-3') Reverse Primer (5'-3')
1 IL-2_1 rs2069772 CCATTCTGAAACAGGAAACCA CTTTAAGGGGGTGGGGATAC
2 IL-2_2 rs2069763 TGCAACTCCTGTCTTGCATT ACTTACATTAATTCCATTCAAAATCA
3 IL-10_4 rs1800894 TCCAGCCACAGAAGCTTACA GTGCTCACCATGACCCCTAC
4 IL-10_5 rs1800871 TCCAGCCACAGAAGCTTACA GTGCTCACCATGACCCCTAC
5 IL-10_6 rs1800872 TCCAGCCACAGAAGCTTACA GTGCTCACCATGACCCCTAC
6 TNFA_7 rs11565 ACCACAGCAATGGGTAGGAG CATGCCCCTCAAAACCTAT
7 TNFA_8 rs673 ACCACAGCAATGGGTAGGAG CGTCCCCTGTATTCCATACCT
8 TNFA_9 rs1800629 GCCCCTCCCAGTTCTAGTTC GCATCAAGGATACCCCTCA
9 TNFA_10 rs361525 GCCCCTCCCAGTTCTAGTTC GCATCAAGGATACCCCTCA
10 IL4_11 rs2243246 GCCCCTCCCAGTTCTAGTTC GCATCAAGGATACCCCTCA
11 IL4_12 rs2243250 AGTGAGTGGTGGGGTCCTTA AATGCCCACTTTTTGAATGG
12 IL4_13 rs34185442 ACCCAAACTAGGCCTCACCT GGTGGCATCTTGGAAACTGT
13 IL4_14 rs2970874 GGAAGAGAGGTGCTGATTGG CGATTTGCAGTGACAATGTG
14 IL6_16 rs1800797 GGAAGAGAGGTGCTGATTGG CGATTTGCAGTGACAATGTG
15 IL6_16 rs1800796 TGGCAAAAAGGAGTCACACA CCCAAGCCTGGGATTATGAAG
16 IL6_17 rs1800795 TGGCAAAAAGGAGTCACACA CCCAAGCCTGGGATTATGAAG
17 IL4R_18 rs1801275 GCTAGCCTCAATGACGACCT TCATGGGAAAATCCCACATT
18 IL4R_19 rs1805011 GAAACCTGGGAGCAGATCCTC GGCCTTGTAACCAGCCTCTC
19 IL4R_20 rs8832 AAAGGGAGCTTCTGTGCATC TCTCCGAGCTGGTCCAG
20 IL4R_21 rs1805015 TTCCTTAGGTTGATGCTGGAG GGTTCCATGCATACGAGGAG
21 IL4R_22 rs1805010 ACCTGACTTGCACAGAGACG AGGGCATGTGGGTTCTACT
22 IL12p40_23 rs3124 GCCTACAGGTGACCAGCCTA AGCCCACGGTCCAGTGTAT
23 STAT6_24 rs167769 CACAACGGAATAGACCCAAAA ATGGCAACTTGAGAGCTGGA
24 STAT6_25 rs324015 GCACTGACTGGAAGGGAAGT CCCTAACCTGTGCTCTTACCC
25 STAT6_26 rs703817 GTCTCAGCCCTAGGGGAATG CTCCACCTGGCTAACAGGAA
26 STAT6_27 rs4559 CAAAAGTACAAGGGCTGA CCCAAATTTGTGTTGTCACG
27 IFNG_28 rs2234685 GGAAGTAGGTGAGGAAGAAGCG TGGAGCAAAGAAGGTCATCA
28 IFNG_29 rs1861493 GGAAGTAGGTGAGGAAGAAGCG TGGAGCAAAGAAGGTCATCA
29 IFNG_30 rs2234687 TCCCATGGGTTGTGTGTTTA GGGTCACCTGACACATTCAA
30 IFNG_31 rs2430561 TTCAGACATTCACAATTGATTTTATTC CCCCAATGGTACAGGTTTCT
31 IFNGR2_34 rs1802585 CCCAACTCAGCCCATCTTAG ATCTCTTCCAGGGAGCCAGT
32 IFNGR2_35 rs1059293 GGGCTGAGCAGTCAGAA CATTTTAAGCCAGCACACCA
33 IFNGR2_36 rs9808753 CAGAGCAGGTCCTGAGTTGGGAGC GTTTCCCACGGGTTTGATAA
34 IRF1_37 rs839 GGACTGTTCCAAAGCCAGTG CAGAAATGTGGCAAGATCCA
35 IRF1_38 rs9282762 TTGCAAACTAAGAAAGCACACAA ATGGGTGACACCTGGAAGTT
36 IRF2_40 rs1131553 CTCCCAAAGTGCTGGGATTA CTGTTGTAAGGCACCGGATT
37 IL8_41 rs1175 CTTCACCATCATGATAGCATCTGT GGAGTATGACGAAAGTTTTCTTTG
38 IL8_42 rs2227307 TGCTTTGGTAACAAACATCCTTT GGTAACCGTCCTTCTCAATAGG
39 IL13_43 rs20541 CTTCCGTGAGGACTGAATGAGAC CTGCAAATAATGATGCTTTCGAAGTTTCAG
40 IL13_44 rs1800925 TGACATCAACACCCAACAGG GCAGAATGAGTGCTGCTGTGGAG
41 IL18_47 rs1946518 GGTCAGTCTTTGCTATCATTCCAG AGCCACACGGATACCATCAT
42 IL18_48 rs1946519 GGTCAGTCTTTGCTATCATTCCAG AGCCACACGGATACCATCAT
43 IL1B_49 rs16944 AGCCTGAACCCTGCATACC CAATAGCCCATCCCTGTCTGT
44 IL1B_50 rs1143627 TCTCAGCCTCCTACTTCTGCTT CAGAGAGACTCCCTTAGCACCT
45 IL1B_51 rs1799916 TCTCAGCCTCCTACTTCTGCTT CAGAGAGACTCCCTTAGCACCT
46 IL1A_52 rs17561 CCCCCTCCAGAACTATTTTCC ACTTTGATTGAGGGCGTCAT
47 IL1A_53 rs1800587 TAGGCTGGCCACAGGAATTA AGCCAGAACCAGTGGCTAAG
48 IL9_56 rs1799962 CCTTCGTTAGAACACCCATGA AGACAGGGATTCTGGTGTGA
49 TNFR1_60 rs1800692 TCCCCCTCCTGTATTCTGTG GTGCACACGGTGTTCTGTTT
50 TNFR1_61 rs1800693 CCTGGAGTGCACGAAGTTGT ATAGATGGATGGGTGGGATG
51 TNFRSF6_62 rs2234768 CATCCTCCTTATCCCACTTCTTT CACCCTGTGTTTTGCATCTA
52 LTA_65 rs1800683 CACTGCCGCTTCCTCTATAA GGTAGTCCAAAGCACGAAGC
53 LTA_66 rs1041981 CCCCCTCAACTCTGTTCTCC GGGAGGTCAGGTGGATGTTT
54 LTA_67 rs909253 GGGTTTGGTTTTGGTTTCCT CAGAGAAACCCCAAGGTGAG
55 IL1RN_68 rs2234676 GCCCATCTCCTCATGCTG GCTGCTGCCCATAAAGTAG
56 IL1RN_69 rs419598 TCCTTTTCAGAATCTGGGATGT CGTGATGCCCAGATACATTG
57 CTLA4_70 rs2384137 AACACCGCTCCCATAAAGC CCTCCTCCATCTTCATGCTC
58 NFKBIA_72 rs1800439 CCTTGTTTTCAGCTGCCCTA TCGTCCCCTACAAAAAGTTCA
59 IL8RB_77 rs2230054 ACATTCCAAGCCTCATGTCC TACCAGGGCAGGCTTTCTA
60 ICAM1_78 rs1799969 CTTGAGGGCACCTACCTCTG AGGATACAACAGGCGGTGAG
61 ICAM1_79 rs5498 CTTGAGGGCACCTACCTCTG AGGATACAACAGGCGGTGAG
62 IL3_81 rs40401 GAGCAGTTAACCCAGCTTGTC CACCTTGCTGCTGCACATA
63 IL3_82 rs31480 GAGCAGTTAACCCAGCTTGTC CACCTTGCTGCTGCACATA
64 MCP1_87 rs4611511 AAAGCTGCCTCCTCAGAGTG CACAGGGAAGGTGAAGGGTA
65 MCP1_88 rs34020694 AGAGAAAACCCGAAGCATGA TCTTCCTAGGCCATCTCACC
66 RANTES_89 rs2107538 ATCCAGAGGACCCTCCTCAA GGAGTGGCAGTTAGGACAGG
67 RANTES_90 rs2280788 TTCTTTTCCGTTTTGTGCAAT CGTGCTGTCTTGATCCTCTG
68 CCR5_91 rs1799863 CTGCCTCCGCTCTACTCACT GCCAGGTTGAGCAGGTAGBMC Genomics 2007, 8:282 http://www.biomedcentral.com/1471-2164/8/282
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biotech (Heidelberg, Germany) according to the manu-
facturer's instructions. The reaction carrier (DNA-proces-
sor) represents a microstructured disposable system that
consists of four or eight individual arrays, respectively,
which can be used individually or in any combination [8].
Controlled by a mask-free, light-controlled process, oligo-
nucleotide probes were synthesized in situ in 3' to 5' direc-
tion [9]. For each selected SNP, 24 oligonucleotide probes
were synthesized, 12 for either DNA strand (Fig. 1), all
designed to exhibit similar hybridization characteristics.
The arrays used in this study consisted of 7,448 distinct
oligonucleotides (594 perfect match probes and 6,534
mismatch probes, plus 320 copies of a control oligonucle-
otide). A complete list can be obtained from the authors.
PCR-amplification
For each SNP, PCR-primers were designed for the amplifi-
cation of the relevant DNA-fragment using the Primer3
program [22]. All primers have a Tm value of 60°C. The
oligonucleotides were obtained from Thermo Hybaid
(Ulm, Germany). Their sequences are presented in the
Table 2. The length of the PCR-products varies between
100 bp and 270 bp.
Genomic DNA from lymphocytes was extracted using the
QiaAmp Blood kit according to the manufacturer's
instructions (Qiagen, Hilden, Germany). PCR-amplifica-
tions of individual loci were carried out in a Mastercycler
gradient thermocycler (Eppendorf-Netheler-Hinz, Ham-
burg, Germany) in 25 µl of 1× Thermoprime polymerase
puffer (AB Gene, Epson, UK), 200 µmol/l of each deoxy-
nucleotide triphosphate (Qiagen), 1.5 mmol/L MgCl2 (AB
Gene), 0.25 units Thermoprime DNA polymerase (AB
Gene), 1.0 to 2.5 µmol/l of both forward and reverse
primer, and 20 ng DNA. The initial annealing occurred at
94°C for 2 min, followed by 30 cycles of 94°C for 40 sec,
57°C for 40 sec and 72°C for 30 sec. Subsequently, a final
extension step was performed at 72°C for 1 min.
Multiplex-PCR was performed in a total volume of 25 µl
solution containing 80 ng human genomic DNA, 1.2
µmol/l of each primer, 1 mmol/l deoxynucleotide tri-
phosphates (dNTPs), 5 mmol/l MgCl2 and 2 units of Ther-
moprime Plus DNA polymerase (AB Gene). All primer
pairs had been checked in silico for possible primer dimers
using the program "Primer Premier 5" (Premier Biosoft
International, Palo Alto, USA).
DNA amplification for individuals, studied in present
work, was done as described in single PCR cycling reac-
tions. All PCR-products were checked by electrophoresis
on 2% agarose gels.
Sample processing
About 200 ng of each PCR-product were pooled and puri-
fied with the QIAquick PCR purification kit (Qiagen)
69 CCR2_94 rs1799865 AGAGGCATAGGGCAGTGAGA GGTCCAGTTGACTGGGTGCTT
70 C5_95 rs17611 TGCAGTTTGCCCTACCTGAT TGCTACCATTTAAGTCCTGGGTA
71 C5_96 rs17612 TTTTAGCTACAAGCCCAGCA AATGAAGCATTCACAACACGA
72 P2X7_97 rs3751143 TTCCTGGACAACCAGAGGAG ACCAGCTTCCTGAACAGCTC
73 IL7R_106 rs1494555 CACTATAGTTAAACCTGAGGCTCC TCCTGGCGGTAAGCTACATC
74 PRF1_107 rs885822 CCCAGGTCAACATAGGCATCC CGAACAGCAGGTCGTTAAT
75 TLR2_108 rs1804965 ATTCTTCTGGAGCCCATTGA GGACTTTATCGCAGCTCTCA
76 TCL1B_109 rs1064017 ACAGTGCACTTGTGGCAG CTGGCCATGGTCTGCTATTT
77 CCR5_110 rs1800452 TAGTCATCTTGGGGCTGGTC TGTAGGGAGCCCAGAAGAGA
78 IL11_111 rs1126757 GGGACCACAACCTGGATTC ATCAGAGAACACCCGACCAG
79 IL11_112 rs2298885 GGCTGTGTTCACCATAGCAA ATCCCAAGCAAGCCTCTCTC
80 IL8RA_117 rs2234671 CATCTTTGCTGTCGTCCTCA CCAGAATCTCAGTGGCATCC
81 IL1L1_118 rs1800930 GATGGTGCTACTGCTGTGGA GGGCTCAGGGTAACACTG
82 CD36_119 rs1334512 CTGGCAACAAACCACACACT TCCTACACTGCAGTCC
83 VDR_121 rs1544410 CCTCACTGCCCTTAGCTCTG CAGGAATGTTGAGCCCAGTT
84 VDR_122 rs7975232 CTGCCGTTGAGTGTCTGTGT ACGTCTGCAGTGTGTTGGAC
85 IL5RA_123 rs2290610 CCATGGCAATGTTTTGTCCT CAGGTGCAGTGAAGGGAAAC
86 IL5R_124 rs2069812 CTTGCTTTTTCCTGCTGCTC AGTCCAGGAATGGAGGCTCT
87 IL5R_125 rs2069818 TGTGGAGAAGAAAGACGGAGA CAAAATCTTTGGCTGCAACAAACCA
88 CX3CR1_126 rs3732379 GGTGGTCATCGTGTTTTTCC AGGCAACAATGGCTAATGC
89 CX3CR1_127 rs3732378 GGTGGTCATCGTGTTTTTCC AGGCAACAATGGCTAATGC
90 TNFRSF1B_128 rs1061622 CTCCTGACCAAGCCTCCTC GTCACTGGCTGGGGTAAGTG
91 TNFRSF1B_129 rs1061624 TCCTCTAGTGCCCTCCACAG CACAGAGAGTCAGGGACTTGC
92 TNFRSF1B_130 rs3397 TCCTCTAGTGCCCTCCACAG CACAGAGAGTCAGGGACTTGC
93 TNFRSF1A_131 rs887477 CAGCACAACTGGTCAGAACC CCTCCTCCCAGTTCAACAAG
94 TNFRSF1A_132 rs4149570 TACAGGAACCCCAGGAGACA TGGGTTCCAATTCAGAATGCTT
95 IL4R_135 rs1805016 GTGTCATGGCCAGGAGGAT AGACTGGCCTCCAGTGGAAC
96 IL6_137 rs20069860 TCCCTCCACTGCAAAGGATT CTGCAGCCACTGGTTCTGT
97 IL9_138 rs20069885 ACTTTCATCC CCACAGT TTGCCTCTCATCCCTCTCAT
98 NKFB_139 rs1020759 TGCTTCCCTCTTGTGTTTCA GGGGATGACCTTTAAGTGGA
99 GATA3_141 rs57013 TCCATCCATTGCACTGAGTC CCAGAGCAGCTGGTTTAAGTG
Table 2: Primer sequences used for PCR-amplification of the SNP-regions. (Continued)BMC Genomics 2007, 8:282 http://www.biomedcentral.com/1471-2164/8/282
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according to the manufacturer's instructions. Biotin 3'-
end labeling was performed as described [8]. In brief, the
eluate resulting from the purification step was dried in a
vacuum concentrator and the pellet was dissolved in 5 µl
of water. Labeling was performed in a total volume of 10
µl with 2.5 U terminal transferase (Roche, Mannheim,
Germany), 0.1 mmol/L Biotin-N6-ddATP (PerkinElmer,
Rodgau, Germany), 2.5 nmol/l CoCl2 and 1× reaction
buffer (Roche). After 1 h incubation at 37°C, the enzyme
was inactivated at 99°C for 15 min and the mixture
cooled on ice.
The final sample hybridization cocktail was made of 10 µl
of this labeling reaction, 4 µl herring sperm DNA (0.1 mg/
mL with 0.5 mg/ml BSA), 9 µl 2 × 2-[N-mor-
pholino]ethanesulfonic (MES) acid buffer [54.8 mmol/l
MES (free acid monohydrate), 147.7 mmol/l MES sodium
salt, 1.8 mol/l NaCl, 40 mmol/l Na2EDTA, 0.02% (v/v)
Tween20] and 6 µl water. As an internal hybridization
control, 1 µl of a mixture of biotin-(50 nmol/l) and Cy5-
labeled (250 nmol/l) control oligonucleotides (GCAGT-
GCTGCCATAACCATGAGTGA, CGCAAACTATTAACT-
GGCGAACTAC, GAACTGGATCTCAACAGCGGTAAGA,
AAGATCAGTTGGGTGCACGAGTGGG, CGCAACAAT-
TAATAGACTGGATGG, GCAGTGCTGCCAAAACCAT-
GAGTGA), supplied by febit biotech, were added. The
total volume of the hybridization mixture was 30 µl,
which was stored frozen until use at -20°C.
Hybridization and detection
The DNA-fragments of all SNPs of one individual person
were analyzed simultaneously in a single hybridization.
The biotin-labeled PCR-products in the hybridization
mixture were denatured at 99°C for 5 min and quickly
cooled on ice for 2 min. The probe arrays were incubated
with 1 × MES solution (containing 1% BSA) at room tem-
perature for 15 min. Then the hybridization mixture was
loaded to the array. Hybridization was performed at 45°C
for 4 h. Subsequently, the used sample was recovered and
the array was washed with 0.5 × SSPE buffer (diluted from
6 × SSPE stock-solution consisting of 0.9 mol/l NaCl, 60
mmol/l NaH2PO4 (pH 7.4) and 6 mmol/l Na2EDTA) at
45°C. Staining was performed with 4 ml of 2.5 µg/ml
streptavidin R-phycoerythrin conjugate (Molecular
Probes, Cologne, Germany) in 6 × SSPE at room temper-
ature for 10 minutes. All these steps were carried out auto-
matically by the GeniomOne instrument.
Data analysis
Image analysis was done automatically with the Gen-
iomOne system-embedded CCD imaging system. All
steps such as configuration of detection parameters,
acquisition of array image, detection of feature position,
calculation of signal intensity and data export to a data-
base were performed automatically. The pattern recogni-
tion rules are digitally encoded in the analysis software,
simplifying and shortening the result reading. Raw data
were further processed with the integrated analysis soft-
ware with the default settings.
Statistical analysis of epidemiological data
The analysis was performed with SAS software PHREG
version 9 (SAS Institute, Cary, USA). Relative risk of the
elevated IgE phenotype associated with genetic variants
was estimated by odds ratios (OR) and associated 95 per-
cent confidence limits using the procedure for conditional
logistic regression. The gene variants were computed as
simultaneous limits of the parameters of a multinomial
distribution according to Nieters et al. [23].
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